Subgroups of parkinsonian patients differentiated by peptidergic immunostaining of caudate nucleus biopsies.
In this study, Met-enkephalin (Met-enk), substance P (SP) and tyrosine hydroxylase (TH) immunostaining was assessed in caudate nucleus biopsies from 15 Parkinson's disease patients who were treated surgically. According to the combination of changes in Met-enk, SP and TH immunostaining, several subgroups of parkinsonian patients were disclosed. Group I: Patients showing low SP and normal Met-enk immunostaining, and variably reduced TH immunoreactivity. Group II: both SP and Met-enk immunostaining were apparently of normal intensity in these PD patients, but they showed the greatest decrease in TH labeling. Group III: PD patients that showed normal SP, very low Met-enk and variably reduced TH immunostaining. Low Met-enk immunostaining tended to correlate with the severity of the disease as judged by higher Unified Parkinson's disease Rating Scale and gait scores. These results suggest that different neurochemical phenotypes may exist among Parkinson's disease patients. Peptidergic deficits should be taken into account for therapeutic intervention.
De Ceballos
M L
ML
Neurodegeneration Group, Cajal Institute, CSIC, Madrid, Spain.
López-Lozano
J J
JJ
D000368:Aged; D000704:Analysis of Variance; D001706:Biopsy; D002421:Caudate Nucleus / Q000033:anatomy & histology / Q000737:chemistry* / Q000201:enzymology; D004744:Enkephalin, Methionine / Q000302:isolation & purification*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009048:Motor Skills; D010300:Parkinson Disease / Q000145:classification*; D018709:Statistics, Nonparametric; D013373:Substance P / Q000302:isolation & purification*; D014446:Tyrosine 3-Monooxygenase / Q000302:isolation & purification
D013373:Substance P; D004744:Enkephalin, Methionine; D014446:Tyrosine 3-Monooxygenase